SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as traders discuss potential bullish formations, including morning star patterns and golden crosses relative to Bitcoin. Community members are focused on key levels and potential breakouts, with some drawing comparisons to other cryptocurrencies like Bitcoin Cash. Discussions also involve Litecoin's positioning relative to emerging blockchain solutions like Keeta.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Recent news of a potential acquisition of Warner Bros. is driving significant conversation around Netflix, with community members weighing the deal's implications. Concerns are emerging about potential debt and regulatory hurdles, while others see the move as solidifying Netflix's dominance in streaming. Discussions also involve speculation around possible government intervention and competing bids.

Treasure Global, Inc. engages in the provision of payment solutions. The firm created an online-to-offline (O2O) e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs. It operates through the ZCITY Platform and Customized Software Development Service segments. The company was founded by Kok Pin Tan on March 20, 2020 and is headquartered in New York, NY.

Treasure Global Inc

TREASURE GLOBAL INC

Treasure Global (TGL) is trending due to a surge in after-hours trading, driven by positive profit outlook news, sparking comparisons to previous runners like $SMX. The community is actively discussing price targets and the potential for a short squeeze, fueled by a low float and high short interest. Some traders believe TGL could reach new highs, while others caution about the risks associated with reverse splits and potential dilution.

Top Wealth Group Holding Ltd. operates as a holding company, which provides caviar and caviar-based gourmet products. It focuses on supplying sturgeon caviar to customers under its own brand, Imperial Cristal Caviar. The company was founded by Kim Kwan Kings Wong on February 1, 2023 and is headquartered in Hong Kong.

Top Wealth Group Holding Ltd. - Ordinary Shares - Class A

Top Wealth Group Holding Ltd.

TWG is trending due to a projected profit outlook for 2025, reversing previous losses, sparking significant after-hours trading volume. Community discussions highlight the stock's low float and potential for a substantial squeeze, drawing comparisons to other recent runners like $TGL and $SMX. Traders are closely watching for continuation and potential retests of higher supply levels.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

IMMX is trending due to a recent upsized offering following promising ASH oral data, signaling strong institutional demand and confidence in the company's direction. The community is focused on the implications of the offering's timing and the potential for accelerated development and a possible buyout.  Broader discussions include the drug's potential impact on AL Amyloidosis treatment and expansion into autoimmune diseases.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

$CVKD is trending as traders discuss its ultra-low float and potential for volatility, making it a watchlist favorite. Some are pointing to bullish technicals, steady accumulation, and news related to Q3 2025 results. The community is also closely watching for a potential breakout.

Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF. The company was founded by Michael R. Green, Danny Reinberg, Rudolf Jaenisch, Jeannie T. Lee, and Bradley E. Bernstein on August 18, 2015, and is headquartered in Cambridge, MA.

Fulcrum Therapeutics Inc

FULC is trending due to positive data from its PIONEER trial for sickle cell disease, presented at the American Society of Hematology meeting. Community discussions highlight the potential for a functional cure and a direct move toward registration trials. Investors are also optimistic about the global sickle cell disease treatment market and FULC's potential leadership in oral therapies.

Wheeler Real Estate Investment Trust, Inc. engages in the acquisition, finance, development, lease, ownership, and management of retail properties. Its property portfolio includes income producing, strip centers, neighborhood, grocery-anchored, community, and free-standing retail properties. The company was founded on June 23, 2011 and is headquartered in Virginia Beach, VA.

Wheeler Real Estate Investment Trust Inc

WHLR is trending due to positive Q3 earnings and high relative volume, sparking discussions about a potential short squeeze. The community is focused on the stock's low float and potential for significant upward movement, drawing comparisons to recent runners like SMX and TGL. Community members are also weighing the risks of possible dilutions and reverse splits.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta (KTA) is trending due to community excitement around its potential as foundational infrastructure for TradFi, emphasized by its high throughput and compliance-aware design. Investors are actively discussing the token's value proposition in comparison to major platforms like Amazon, Google, and Microsoft, viewing KTA as a targeted bet on the future of financial plumbing. The community also highlights potential partnerships, particularly with Stripe, as a key catalyst.

Owens Corning engages in the development, manufacture, and marketing of insulation, roofing, and fiberglass composites. It operates through the following segments: Composites, Insulation, and Roofing. The Composites segment manufactures, fabricates, and sells glass reinforcements in the form of fiber, and includes vertically integrated downstream activities. The Insulation segment provides insulating products which help customers conserve energy, provide improved acoustical performance, and offer convenience of installation and use. The Roofing segment offers laminate and strip asphalt roofing shingles and other products including oxidized asphalt and roofing accessories. The company was founded on October 31, 1938, and is headquartered in Toledo, OH.

Owens Corning

Owens Corning ($OC) is trending amid discussion of updated analyst ratings and price targets, with community members sharing both bullish and bearish perspectives. Some are liking the construction sector outlook for 2026, while others are wary of potential pullbacks given the stock's technical indicators. Discussions also include recent free trade alerts, potential acquisitions, and the impact of housing market trends.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Dyne Therapeutics Stock Down 30% in a Year So Why Did One Investor Add Nearly 1 Million Shares?

Key PointsCalifornia-based Palo Alto Investors acquired 997,698 DYN shares in the third quarter...

Franklin Resources Inc. Cuts Stock Holdings in Dyne Therapeutics, Inc. $DYN

Franklin Resources Inc. lessened its holdings in Dyne Therapeutics, Inc. (NASDAQ:DYN - Free Report) by 1.7% during the second quarter, according to its most recent filing with the Securities and...

Ensign Peak Advisors Inc Has $2.53 Million Position in Dyne Therapeutics, Inc. $DYN

Ensign Peak Advisors Inc grew its holdings in Dyne Therapeutics, Inc. (NASDAQ:DYN - Free Report) by 1,220.5% during the second quarter, according to its most recent 13F filing with the Securities and...

Dyne Therapeutics, Inc. (NASDAQ:DYN) Given Consensus Rating of "Moderate Buy" by Analysts

Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the eighteen research firms that are presently covering the stock...

Dyne Therapeutics (NASDAQ:DYN) Trading 9% Higher - Here's What Happened

Dyne Therapeutics (NASDAQ:DYN) Shares Up 9% - Still a Buy...

Candriam S.C.A. Purchases 60,793 Shares of Dyne Therapeutics, Inc. $DYN

Candriam S.C.A. grew its holdings in shares of Dyne Therapeutics, Inc. (NASDAQ:DYN - Free Report) by 13.1% during the second quarter, according to the company in its most recent filing with the...

Dyne Therapeutics (NASDAQ:DYN) Price Target Cut to $17.00 by Analysts at JPMorgan Chase & Co.

JPMorgan Chase & Co. lowered their price target on shares of Dyne Therapeutics from $18.00 to $17.00 and set a "neutral" rating on the stock in a research note on Friday...

Oppenheimer Lowers Dyne Therapeutics (NASDAQ:DYN) Price Target to $11.00

Oppenheimer reduced their price objective on Dyne Therapeutics from $13.00 to $11.00 and set a "market perform" rating for the company in a research report on Wednesday...

HC Wainwright Predicts Lower Earnings for Dyne Therapeutics

Dyne Therapeutics, Inc. (NASDAQ:DYN - Free Report) - Investment analysts at HC Wainwright lowered their FY2025 earnings per share (EPS) estimates for shares of Dyne Therapeutics in a research report...

Lifesci Capital Has Positive Outlook of DYN FY2025 Earnings

Dyne Therapeutics, Inc. (NASDAQ:DYN - Free Report) - Analysts at Lifesci Capital boosted their FY2025 earnings estimates for Dyne Therapeutics in a research note issued to investors on Thursday...

Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA.

Dyne Therapeutics Inc

$SOFI

$RDDT

$CVNA

$MSTR

Which stock do you think gets added to the S&amp;P 500 in today’s rebalance?

Stocktwits

Which stock do you think gets added to the S&P 500 in today’s rebalance?

DYN
Dyne Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest DYN News

DYNDyne Therapeutics Inc